Immunic, Inc. (IMUX)
16.46
-0.04
(-0.24%)
USD |
NASDAQ |
Aug 24, 16:00
16.50
+0.04
(+0.24%)
After-Hours: 20:00
Immunic Debt to Equity Ratio : 0.0044 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0044 |
| March 31, 2026 | 0.0028 |
| December 31, 2025 | -0.0865 |
| September 30, 2025 | 0.0754 |
| June 30, 2025 | 0.0289 |
| March 31, 2025 | -0.1844 |
| December 31, 2024 | 0.0545 |
| September 30, 2024 | 0.0218 |
| June 30, 2024 | 0.015 |
| March 31, 2024 | 0.0135 |
| December 31, 2023 | 0.0461 |
| September 30, 2023 | 0.03 |
| June 30, 2023 | 0.0272 |
| March 31, 2023 | 0.0219 |
| December 31, 2022 | 0.0137 |
| September 30, 2022 | 0.0106 |
| June 30, 2022 | 0.006 |
| March 31, 2022 | 0.0066 |
| December 31, 2021 | 0.0078 |
| September 30, 2021 | 0.0076 |
| June 30, 2021 | 0.0084 |
| March 31, 2021 | 0.0095 |
| December 31, 2020 | 0.0043 |
| September 30, 2020 | 0.0045 |
| June 30, 2020 | 0.0101 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0093 |
| December 31, 2019 | 0.0089 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0036 |
| December 31, 2018 | -1.445 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Sionna Therapeutics, Inc. | 0.0304 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 159.17M |
| Total Liabilities (Quarterly) | 31.59M |
| Shareholders Equity (Quarterly) | 127.58M |
| Current Ratio | 5.049 |
| Net Debt Paydown Yield | 0.04% |